Valued at $110.1M at its later-stage round, Nov 2023. Nothing has traded since.
- ·The complete investor list: 16 names
- ·Watch Prellis Biologics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Prellis Biologics funding history
5 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2022 | Early Stage VC | $17.0M | ▮ | ▮ |
| Jul 2021 | Early Stage VC | $19.3M | ▮ | ▮ |
| Mar 2019 | Early Stage VC | $8.7M | ▮ | ▮ |
| Jan 2018 | Seed Round | $460K | ▮ | ▮ |
| Jun 2017 | Seed Round | $1.8M | ▮ | ▮ |
Membership and data by Private Market View
Prellis Biologics valuation
Prellis Biologics was valued at $110 million at its later-stage round in Nov 2023. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Prellis Biologics raised?
Prellis Biologics has raised $70.2 million across 5 recorded rounds since 2017. The largest was an $8.7 million early-stage round in Mar 2019; the most recent was a $17 million early-stage round in Jun 2022.
Prellis Biologics has filed 5 Form Ds with the SEC since 2017, most recently in Jul 2022 ($17 million sold to 19 investors).
How Prellis Biologics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Prellis Biologics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Prellis Biologics
- What is Prellis Biologics worth?
- Prellis Biologics is valued at $110.1M as of Oct 2026. Valued at $110.1M at its later-stage round, Nov 2023. Nothing has traded since.
- How much has Prellis Biologics raised?
- Prellis Biologics has raised $70.2M in total funding across 5 recorded rounds.
- When did Prellis Biologics last raise?
- Prellis Biologics last raised in Jun 2022 (Early Stage VC), raising $17.0M.